ES2111960T3 - Analogos de nucleosidos bloqueados conformacionalmente. - Google Patents

Analogos de nucleosidos bloqueados conformacionalmente.

Info

Publication number
ES2111960T3
ES2111960T3 ES94929321T ES94929321T ES2111960T3 ES 2111960 T3 ES2111960 T3 ES 2111960T3 ES 94929321 T ES94929321 T ES 94929321T ES 94929321 T ES94929321 T ES 94929321T ES 2111960 T3 ES2111960 T3 ES 2111960T3
Authority
ES
Spain
Prior art keywords
analogs
conformationally locked
carbociclic
nucleosides
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94929321T
Other languages
English (en)
Inventor
Victor E Marquez
Juan B Rodriguez
Marc C Nicklaus
Joseph J Barchi Jr
Maqbool A Siddiqui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2111960T3 publication Critical patent/ES2111960T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ANALOGOS DE NUCLEOSIDOS CARBOCICLICOS FUSIONADOS A 4'',6''CICLOPROPANO, BLOQUEADOS CONFORMACIONALMENTE. LOS COMPUESTOS SE PREPARAN CONDENSANDO UN ALCOHOL ALILICO CARBOCICLICO FUSIONADO A CICLOPROPANO CON BASES DE PURINA O DE PIRIMIDINA SUSTITUIDAS. LOS PRODUCTOS DE CONDENSACION SE MODIFICAN ENTONCES PARA PRODUCIR ANALOGOS DE NUCLEOSIDOS DE ADENOSINA, GUANOSINA, CITIDINA, TIMIDINA Y URACILO. LOS COMPUESTOS SON TERAPEUTICAMENTE UTILES COMO ANTIMETABOLITOS, O PARA LA PREPARACION DE AGENTES ANTIMETABOLICOS.
ES94929321T 1993-09-24 1994-09-23 Analogos de nucleosidos bloqueados conformacionalmente. Expired - Lifetime ES2111960T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12679693A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
ES2111960T3 true ES2111960T3 (es) 1998-03-16

Family

ID=22426712

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94929321T Expired - Lifetime ES2111960T3 (es) 1993-09-24 1994-09-23 Analogos de nucleosidos bloqueados conformacionalmente.

Country Status (10)

Country Link
US (2) US5629454A (es)
EP (1) EP0720604B1 (es)
JP (1) JP3481945B2 (es)
AT (1) ATE160340T1 (es)
AU (1) AU677441B2 (es)
DE (1) DE69406943T2 (es)
DK (1) DK0720604T3 (es)
ES (1) ES2111960T3 (es)
GR (1) GR3026166T3 (es)
WO (1) WO1995008541A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005662A1 (en) * 1996-08-07 1998-02-12 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Conformationally locked nucleoside analogs as antiherpetic agents
US5840728A (en) * 1996-08-07 1998-11-24 United States Of America As Represented By The Department Of Health And Human Services Conformationally locked nucleoside analogs as antiherpetic agents
US7087589B2 (en) 2000-01-14 2006-08-08 The United States Of America As Represented By The Department Of Health And Human Services Methanocarba cycloakyl nucleoside analogues
ATE442360T1 (de) * 2000-07-26 2009-09-15 Us Gov Health & Human Serv 5-substituierte pyrimidinderivate eines konformatiosfestgelegten nukleosidanalogen
US20030032028A1 (en) * 2001-06-12 2003-02-13 Gayle Dace In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads
US20020187479A1 (en) * 2001-06-12 2002-12-12 Gayle Dace In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads
EP1509624A2 (en) * 2002-05-31 2005-03-02 Secretary, Department Of Atomic Energy Met/fret based method of target nucleic acid detection whereby the donor/acceptor moieties are on complementary strands
US20060147924A1 (en) * 2002-09-11 2006-07-06 Ramsing Neils B Population of nucleic acids including a subpopulation of lna oligomers
WO2006091905A1 (en) * 2005-02-25 2006-08-31 Gilead Sciences, Inc. Bicyclo (3.1.0) hexane derivatives as antiviral compounds
US20090221523A1 (en) * 2005-05-25 2009-09-03 Tseng Christopher K North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses
WO2011068978A1 (en) 2009-12-02 2011-06-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives and dendrimer conjugates thereof
EP3119789B1 (en) 2014-03-17 2020-04-22 Ionis Pharmaceuticals, Inc. Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
WO2016022563A1 (en) 2014-08-04 2016-02-11 Auburn University Enantiomers of the 1',6'-isomer of neplanocin a
KR101875997B1 (ko) 2015-05-04 2018-07-06 엔 앤드 엔 파마세우티칼스 인크. 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577558A2 (de) * 1992-07-01 1994-01-05 Ciba-Geigy Ag Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte

Also Published As

Publication number Publication date
DK0720604T3 (da) 1998-07-27
DE69406943T2 (de) 1998-05-07
WO1995008541A1 (en) 1995-03-30
US5869666A (en) 1999-02-09
EP0720604B1 (en) 1997-11-19
JPH09502986A (ja) 1997-03-25
AU7842094A (en) 1995-04-10
US5629454A (en) 1997-05-13
EP0720604A1 (en) 1996-07-10
JP3481945B2 (ja) 2003-12-22
DE69406943D1 (de) 1998-01-02
AU677441B2 (en) 1997-04-24
GR3026166T3 (en) 1998-05-29
ATE160340T1 (de) 1997-12-15

Similar Documents

Publication Publication Date Title
ES2111960T3 (es) Analogos de nucleosidos bloqueados conformacionalmente.
KR950700298A (ko) 뉴클레오시드 치료제(Therapeutic Nucleosides)
IT8819996A0 (it) Procedimento per la fabbricazione di un velo da filare da filamento sintetico continuo.
BR8806801A (pt) Derivado de pirimidina,composicao herbicida,processo para matar ervas daninhas,processo para produzir um derivado de pirimidina,processo para produzir um acido 2,6-bis-((4,6-dissubstituido pirimidin-2-ii)oxi)benzoico e processo para produzir um composto
ES508434A0 (es) "un procedimiento continuo para recuperar acetonitrilo muy puro de acetonitrilo bruto".
ATE133678T1 (de) 9-purinyl-phosphonsäurederivate
FR2543018B1 (fr) Procede de preparation de vesicules lipidiques par vaporisation de solvants
ATE299509T1 (de) Neue 2'-o-alkyl-nukleoside und -phosphoramidite, verfahren zu ihrer herstellung und ihre verwendungen
ES492456A0 (es) Un procedimiento para la preparacion de 5'-deoxi-5-fluo- rouridina
FI91763C (fi) Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi
BR9807406A (pt) Formulação farmacêutica, e, processo para a preparação das mesmas
ES2037425T3 (es) Procedimiento para la preparacion de 1,1-dicloro-1-fluoroetano.
IT1146940B (it) Composti 2,4-diamminopirido (2,3-d) pirimidinici dotati di attivita' farmacologica e procedimento per la loro preparazione
EP0521463A3 (en) Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents
SE7808771L (sv) 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)pyrimidiner jemte sett for deras framstellning
DK0452729T3 (da) Fremgangsmåde til fremstilling af substituerede cyclobutaner
MX9207468A (es) Proceso para preparar acido 2,6-naftalenodicarboxilico purificado.
AR231141A1 (es) Procedimiento para obtener nitratos de alquilamino-desoxi-1.4;3.6-dianhidrohexito,sustituidos por bases purinicas
NO974512D0 (no) Fremgangsmåte for syntese av nukleosid-analoger
IT1130491B (it) Procedimento per la preparazione di schiume sintetiche mediante reazioni di condensazione
DK0472181T3 (da) 5-Amino-substituerede adenosinanaloge som immunsuppresiva
JPS5677298A (en) Movel 5-fluorouridine derivative and its preparation
ES521739A0 (es) Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas.
FR2654091B1 (fr) Procede de fabrication d'analogues de l'alumine-beta.
GB9111967D0 (en) 2,5'-nucleotide analogs as antiviral agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 720604

Country of ref document: ES